Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Lambe

Showing results (161-170 of 239) with videos related to

Pageof 24
Sort By:
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
European Journal of Haematology|February 3, 2016
Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalenceNiklas Gunnarsson, Fredrik Sandin, Martin Höglund, et al.
Scandinavian Journal of Urology|April 29, 2021
Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemicGiuseppe Fallara, Fredrik Sandin, Johan Styrke, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2012
Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe SwedenAndreas Thorstenson, Ola Bratt, Olof Akre, et al.
International Journal of Molecular Epidemiology and Genetics|June 23, 2012
Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS studyDivya Seth, Hans Garmo, Annette Wigertz, et al.
Ecancermedicalscience|September 14, 2017
Serum biomarkers to predict risk of testicular and penile cancer in AMORISArunangshu Ghoshal, Hans Garmo, Rhonda Arthur, et al.
Scientific Reports|October 20, 2020
In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to SwedenArnar S Agustsson, Helgi Birgisson, Bjarni A Agnarsson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohortLorelei A Mucci, Paul W Dickman, Mats Lambe, et al.
The Lancet. Oncology|April 17, 2010
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe SwedenMieke Van Hemelrijck, Jan Adolfsson, Hans Garmo, et al.
Pageof 24

Showing results (161-170 of 239) with videos related to

Sort By:
Pageof 24
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
European Journal of Haematology|February 3, 2016
Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalenceNiklas Gunnarsson, Fredrik Sandin, Martin Höglund, et al.
Scandinavian Journal of Urology|April 29, 2021
Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemicGiuseppe Fallara, Fredrik Sandin, Johan Styrke, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2012
Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe SwedenAndreas Thorstenson, Ola Bratt, Olof Akre, et al.
International Journal of Molecular Epidemiology and Genetics|June 23, 2012
Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS studyDivya Seth, Hans Garmo, Annette Wigertz, et al.
Ecancermedicalscience|September 14, 2017
Serum biomarkers to predict risk of testicular and penile cancer in AMORISArunangshu Ghoshal, Hans Garmo, Rhonda Arthur, et al.
Scientific Reports|October 20, 2020
In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to SwedenArnar S Agustsson, Helgi Birgisson, Bjarni A Agnarsson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohortLorelei A Mucci, Paul W Dickman, Mats Lambe, et al.
The Lancet. Oncology|April 17, 2010
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe SwedenMieke Van Hemelrijck, Jan Adolfsson, Hans Garmo, et al.
Pageof 24